• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GTG 3.09% 9.4¢

GENETIC TECHNOLOGIES LIMITED

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and morMore

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
GTG
News: GTG Genetic Technologies Expands Operational Capacity In North America
18/06/24 0 93
18/06/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  93 
GTG 18/06/24 3 1.0K
18/06/24 Last post  lived79 Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
GTG
News: GTG Genetic Technologies Says Expands Operational Capacity In North America
18/06/24 0 97
Metals & Mining SECTOR NEWS

A mountain of untapped potential: Chariot Corporation (ASX:CC9) commences discovery-level drill program in Wyoming, USA

CC9
19 Jun 2024
CHARIOT CORPORATION LTD
18/06/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  97 
GTG 18/06/24 0 214
18/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  214 
GTG 12/06/24 0 225
12/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  225 
GTG 05/06/24 0 254
05/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  254 
GTG
At-home saliva test could help diagnose Prostate cancer sooner
03/06/24 2 740
03/06/24 Last post  emusan Comments Created with Sketch.  2  Views Created with Sketch.  740 
GTG 31/05/24 5 1.5K
31/05/24 Last post  redpill Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 

See All Discussions arrow Created with Sketch.

Timeline

GTG Expands Operational Capacity in North America
18 Jun 09:31
 
Notification regarding unquoted securities - GTG
12 Jun 13:53
 
GeneType and Stayhealthy Announce Landmark Distribution Agre
05 Jun 14:44
 
Change in substantial holding
05 Jun 08:24
 
Launch of test for 100% risk of breast and ovarian cancer
29 May 09:32
 
Form F-1 Registration Statement
20 May 10:20
 
View More arrow Created with Sketch.
(20min delay)
Last
9.4¢
Change
-0.003(3.09%)
Mkt cap ! $12.42M
Open High Low Value Volume
9.1¢ 9.5¢ 8.7¢ $41.91K 460.3K

Buyers (Bids)

No. Vol. Price($)
1 10275 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 76366 1
View Market Depth
Last trade - 13.43pm 19/06/2024 (20 minute delay) ?
Last
9.0¢
  Change
-0.003 ( 7.22 %)
Open High Low Volume
9.0¢ 9.0¢ 9.0¢ 14564
Last updated 13.24pm 19/06/2024 ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.